Literature DB >> 17513735

Tumor exosomes inhibit differentiation of bone marrow dendritic cells.

Shaohua Yu1, Cunren Liu, Kaihong Su, Jianhua Wang, Yuelong Liu, Liming Zhang, Chuanyu Li, Yingzi Cong, Robert Kimberly, William E Grizzle, Carla Falkson, Huang-Ge Zhang.   

Abstract

The production of exosomes by tumor cells has been implicated in tumor-associated immune suppression. In this study, we show that, in mice, exosomes produced by TS/A murine mammary tumor cells target CD11b(+) myeloid precursors in the bone marrow (BM) in vivo, and that this is associated with an accumulation of myeloid precursors in the spleen. Moreover, we demonstrate that TS/A exosomes block the differentiation of murine myeloid precursor cells into dendritic cells (DC) in vitro. Addition of tumor exosomes at day 0 led to a significant block of differentiation into DC, whereas addition at later time points was less effective. Similarly, exosomes produced by human breast tumor cells inhibited the differentiation of human monocytes in vitro. The levels of IL-6 and phosphorylated Stat3 were elevated 12 h after the tumor exosome stimulation of murine myeloid precursors, and tumor exosomes were less effective in inhibiting differentiation of BM cells isolated from IL-6 knockout mice. Addition of a rIL-6 to the IL-6 knockout BM cell culture restored the tumor exosome-mediated inhibition of DC differentiation. These data suggest that tumor exosome-mediated induction of IL-6 plays a role in blocking BM DC differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513735     DOI: 10.4049/jimmunol.178.11.6867

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  183 in total

1.  The biology of incipient, pre-invasive or intraepithelial neoplasia.

Authors:  William E Grizzle; Sudhir Srivastava; Upender Manne
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.

Authors:  Yuelong Liu; Xiaoyu Xiang; Xiaoying Zhuang; Shuangyin Zhang; Cunren Liu; Ziqiang Cheng; Sue Michalek; William Grizzle; Huang-Ge Zhang
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

Review 3.  Exosomes: immune properties and potential clinical implementations.

Authors:  Nathalie Chaput; Clotilde Théry
Journal:  Semin Immunopathol       Date:  2010-12-21       Impact factor: 9.623

Review 4.  Tumor-derived exosomes in oncogenic reprogramming and cancer progression.

Authors:  Sarmad N Saleem; Asim B Abdel-Mageed
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

Review 5.  The exosomes in tumor immunity.

Authors:  Yanfang Liu; Yan Gu; Xuetao Cao
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

6.  Induction of myeloid-derived suppressor cells by tumor exosomes.

Authors:  Xiaoyu Xiang; Anton Poliakov; Cunren Liu; Yuelong Liu; Zhong-bin Deng; Jianhua Wang; Ziqiang Cheng; Spandan V Shah; Gui-Jun Wang; Liming Zhang; William E Grizzle; Jim Mobley; Huang-Ge Zhang
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

7.  Differential in vivo biodistribution of 131I-labeled exosomes from diverse cellular origins and its implication for theranostic application.

Authors:  Mohammad H Rashid; Thaiz F Borin; Roxan Ara; Kartik Angara; Jingwen Cai; Bhagelu R Achyut; Yutao Liu; Ali S Arbab
Journal:  Nanomedicine       Date:  2019-08-01       Impact factor: 5.307

8.  BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

Authors:  Aldo M Roccaro; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Yu-Tzu Tai; Michaela Reagan; Feda Azab; Ludmila M Flores; Federico Campigotto; Edie Weller; Kenneth C Anderson; David T Scadden; Irene M Ghobrial
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

9.  Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivo.

Authors:  Ferdinando Pucci; Mikael J Pittet
Journal:  Clin Cancer Res       Date:  2013-02-20       Impact factor: 12.531

10.  Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy.

Authors:  Marta Szajnik; Magdalena Derbis; Michal Lach; Paulina Patalas; Marcin Michalak; Hanna Drzewiecka; Dariusz Szpurek; Andrzej Nowakowski; Marek Spaczynski; Włodzimierz Baranowski; Theresa L Whiteside
Journal:  Gynecol Obstet (Sunnyvale)       Date:  2013-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.